HIV-1 drug resistance in people on dolutegravir-based ART: Collaborative analysis of cohort studies
Tom Loosli, Stefanie Hossmann, Suzanne M. Ingle, Hajra Okhai, Katharina Kusejko, Johannes Mouton, Pantxika Bellecave, Ard van Sighem, Melanie Stecher, Antonella d’Arminio Monforte, M. John Gill, Caroline A. Sabin, Gary Maartens, Huldrych F. Günthard, Jonathan A. C. Sterne, Richard Lessells, View ORCID ProfileMatthias Egger, Roger Kouyos
doi: https://doi.org/10.1101/2023.04.05.23288183
Tom Loosli
1Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland
2Institute of Medical Virology, University of Zurich, Zurich, Switzerland
Stefanie Hossmann
3Institute of Social and Preventive Medicine (ISPM), University of Bern, Switzerland
Suzanne M. Ingle
4Population Health Sciences, Bristol Medical School, University of Bristol, UK
Hajra Okhai
5Institute for Global Health, University College London, UK
Katharina Kusejko
1Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland
2Institute of Medical Virology, University of Zurich, Zurich, Switzerland
Johannes Mouton
6Department of Medicine, University of Cape Town, Cape Town, South Africa
Pantxika Bellecave
7Virology laboratory, University Hospital Bordeaux, Bordeaux, France
Ard van Sighem
8Stichting hiv monitoring, Amsterdam, the Netherlands
Melanie Stecher
9German Center for Infection Research (DZIF), Partner-Site Cologne-Bonn, Cologne, Germany
10University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf
Antonella d’Arminio Monforte
11Italian Cohort Naive Antiretrovirals, (ICONA) L’Azienda Socio Sanitaria Territoriale (ASST) Santi Paolo e Carlo, Milano, Italy
M. John Gill
12Southern Alberta Clinic, Calgary, AB, Canada
13Department of Medicine, University of Calgary, Calgary, AB, Canada
Caroline A. Sabin
5Institute for Global Health, University College London, UK
Gary Maartens
6Department of Medicine, University of Cape Town, Cape Town, South Africa
Huldrych F. Günthard
1Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland
2Institute of Medical Virology, University of Zurich, Zurich, Switzerland
Jonathan A. C. Sterne
4Population Health Sciences, Bristol Medical School, University of Bristol, UK
Richard Lessells
15Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa
16Centre for Infectious Disease Epidemiology and Research, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa
Matthias Egger
3Institute of Social and Preventive Medicine (ISPM), University of Bern, Switzerland
4Population Health Sciences, Bristol Medical School, University of Bristol, UK
16Centre for Infectious Disease Epidemiology and Research, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa
Roger Kouyos
1Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland
2Institute of Medical Virology, University of Zurich, Zurich, Switzerland
Data Availability
Data underlying the figures and tables reported in this article may be shared following publication of this article. Researchers may submit a methodologically sound proposal for the use of these data to the corresponding author. De-identified data of individual study participants cannot be made available as they are subject to the respective observational HIV cohorts.
Posted April 05, 2023.
HIV-1 drug resistance in people on dolutegravir-based ART: Collaborative analysis of cohort studies
Tom Loosli, Stefanie Hossmann, Suzanne M. Ingle, Hajra Okhai, Katharina Kusejko, Johannes Mouton, Pantxika Bellecave, Ard van Sighem, Melanie Stecher, Antonella d’Arminio Monforte, M. John Gill, Caroline A. Sabin, Gary Maartens, Huldrych F. Günthard, Jonathan A. C. Sterne, Richard Lessells, Matthias Egger, Roger Kouyos
medRxiv 2023.04.05.23288183; doi: https://doi.org/10.1101/2023.04.05.23288183
HIV-1 drug resistance in people on dolutegravir-based ART: Collaborative analysis of cohort studies
Tom Loosli, Stefanie Hossmann, Suzanne M. Ingle, Hajra Okhai, Katharina Kusejko, Johannes Mouton, Pantxika Bellecave, Ard van Sighem, Melanie Stecher, Antonella d’Arminio Monforte, M. John Gill, Caroline A. Sabin, Gary Maartens, Huldrych F. Günthard, Jonathan A. C. Sterne, Richard Lessells, Matthias Egger, Roger Kouyos
medRxiv 2023.04.05.23288183; doi: https://doi.org/10.1101/2023.04.05.23288183
Subject Area
Subject Areas
- Addiction Medicine (400)
- Allergy and Immunology (711)
- Anesthesia (202)
- Cardiovascular Medicine (2954)
- Dermatology (250)
- Emergency Medicine (443)
- Epidemiology (12763)
- Forensic Medicine (12)
- Gastroenterology (829)
- Genetic and Genomic Medicine (4598)
- Geriatric Medicine (420)
- Health Economics (730)
- Health Informatics (2934)
- Health Policy (1069)
- Hematology (389)
- HIV/AIDS (925)
- Medical Education (427)
- Medical Ethics (116)
- Nephrology (470)
- Neurology (4373)
- Nursing (237)
- Nutrition (640)
- Oncology (2277)
- Ophthalmology (647)
- Orthopedics (258)
- Otolaryngology (325)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (502)
- Pediatrics (1197)
- Primary Care Research (499)
- Public and Global Health (6963)
- Radiology and Imaging (1532)
- Respiratory Medicine (915)
- Rheumatology (440)
- Sports Medicine (385)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (181)